Flagship explainer
What drives IOVANCE BIOTHERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$391M | FY2025 |
| |
| Income before tax | −$393M | FY2025 |
|
| Operating income | −$403M | FY2025 |
|
| $264M | FY2025 |
| |
| Ending assets | $913M | FY2025 |
|
| Beginning assets | $910M | FY2024 |
|
| $699M | FY2025 |
| |
| $710M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-018899